HAVCR2 and gastric cancer: Few studies have specifically evaluated the expression of LAG3 and TIGIT in CD8 T-cells in gastric cancer, however, Park and colleagues previously showed that high immune checkpoint receptor expression (including PD-1, LAG3 and TIM3) in CD8 + T-cells was associated with improved survival in gastric cancer.